These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15228370)

  • 1. Anticipating the future: how the emergence of innovative biologic agents impacts benefit design, utilization, and provider relations.
    Lipsy RJ; Fuller MG; Roski J; Mansukani S
    J Manag Care Pharm; 2004 May; 10(3 Suppl):S4-9; quiz S19. PubMed ID: 15228370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications.
    J Manag Care Spec Pharm; 2019 Feb; 25(2):156-162. PubMed ID: 30698091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable biologic case studies.
    Lipsy RJ
    J Manag Care Pharm; 2004 May; 10(3 Suppl):S10-6; quiz S20. PubMed ID: 15228371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit design innovations to manage specialty pharmaceuticals.
    Stern D
    J Manag Care Pharm; 2008 May; 14(4 Suppl):S12-6. PubMed ID: 18507509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 7. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
    Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
    J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed care and reproductive health.
    Cohen SS; Williams DR
    J Nurse Midwifery; 1998; 43(3):150-61. PubMed ID: 9674347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.
    Garrison LP; Neumann PJ; Willke RJ
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1185-1192. PubMed ID: 31663458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.
    2018-2019 Academy of Managed Care Pharmacy Professional Practice Committee
    J Manag Care Spec Pharm; 2019 Jun; 25(6):641-644. PubMed ID: 30977701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer: complexities and challenges in managed care.
    Minkoff NB
    J Manag Care Pharm; 2007 Aug; 13(6 Suppl C):S27-9. PubMed ID: 17713992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milestones in managed care pharmacy.
    Cantrell S; Reilly C
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1379-1383. PubMed ID: 33119449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practices in specialty pharmacy management.
    Patterson CJ
    J Manag Care Pharm; 2013; 19(1):42-8. PubMed ID: 23383699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed approaches to multiple sclerosis in special populations.
    Sperandeo K; Nogrady L; Moreo K; Prostko CR
    J Manag Care Pharm; 2011; 17(9 Suppl C):S1-19; quiz S20-1. PubMed ID: 22107156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting the focus from cost to value: a government perspective.
    Edgar BS
    J Manag Care Pharm; 2006 Aug; 12(6 Suppl B):S11-5; quiz S24-6. PubMed ID: 17274691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist.
    Johnson SG
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S19-25. PubMed ID: 19678723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit.
    Bendicksen L; Kesselheim AS
    J Manag Care Spec Pharm; 2022 Mar; 28(3):354-361. PubMed ID: 35199580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for assessing the cost of biologic agents in the treatment of psoriasis.
    Rich SJ
    J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S38-41. PubMed ID: 15253689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing and implementing an effective specialty pharmacy service program.
    Morrow TJ
    Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.